tirzepatide taken off market Grey tirzepatide: what you need to know before risking your health Tirzepatide Injections for Weight Loss

Some patients maintain their weight loss after stopping with lifestyle changes alone, but this is not the norm

Novo Nordisk has not yet reported a subgroup analysis for these patients, but such an analysis could offer useful insights into whether GLP-1RAs confer cognitive advantage in this subgroup

Required documentation for PA: Complete medical history and physical exam notes Current height, weight, BMI calculation List of weight-related comorbidities with diagnostic codes Lab results (A1C, lipid panel, metabolic panel) Documentation of lifestyle intervention attempts and outcomes Letter of medical necessity from prescribing provider Confirmation of no contraindications Common reasons for PA denial: BMI doesn't meet plan threshold (patient has BMI 27-29.9, plan requires 30+) Insufficient documentation of lifestyle intervention failure Missing required lab work Presence of contraindication (history of pancreatitis, family history of medullary thyroid cancer) Medication not on plan formulary If your PA is denied, you have the right to appeal

With a convenient once-weekly injection schedule, semaglutide provides consistent appetite control between doses